Savaş Gegin, Samsun Training and Research Hospital, 55090 İlkadım/Samsun, Turkey,
Croat Med J. 2024 Oct 31;65(5):450-453. doi: 10.3325/cmj.2024.65.450.
Alpha-1 antitrypsin deficiency (AATD) is a rare autosomal co-dominant disease caused by mutations in the SERPINA1 gene. The alleles most frequently associated with AATD are protease inhibitors S and Z. Here, we report on a 35-year-old woman diagnosed with Kartagener's syndrome and subsequently referred for bronchiectasis testing. She was identified with a hitherto unreported AATD mutation: a heterozygous variant rs1460874866 in a previously undefined exon 4 (NM_001127701.1) of the SERPINA1 gene. Although Kartagener's syndrome is a genetic cause of bronchiectasis, patients with this syndrome are recommended to undergo AATD testing.
α-1 抗胰蛋白酶缺乏症(AATD)是一种罕见的常染色体共显性疾病,由 SERPINA1 基因突变引起。与 AATD 最常相关的等位基因是蛋白酶抑制剂 S 和 Z。在这里,我们报告了一位 35 岁的女性,被诊断为卡他性综合征,随后被转介进行支气管扩张症检测。她被确定携带一种迄今尚未报道的 AATD 突变:SERPINA1 基因外显子 4(NM_001127701.1)中一个先前未定义的杂合变异 rs1460874866。尽管卡他性综合征是支气管扩张症的遗传原因,但建议患有这种综合征的患者进行 AATD 检测。